- Report
- October 2024
- 191 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- July 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- July 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3818EUR$4,000USD£3,199GBP
- Report
- January 2021
Global
From €2386EUR$2,500USD£1,999GBP
€4772EUR$5,000USD£3,998GBP
The Microbiomics market is a subset of the Genomics market, focusing on the study of microbial genomes. It is a rapidly growing field, with applications in a variety of industries, including healthcare, agriculture, and food production. Microbiomics research is used to identify and characterize microbial communities, as well as to understand their role in human health and disease. It is also used to develop new treatments and therapies, as well as to improve food safety and quality.
Microbiomics research is enabled by advances in sequencing technologies, which allow for the rapid and cost-effective analysis of microbial genomes. This has enabled the development of new tools and techniques for the study of microbial communities, such as metagenomics and metatranscriptomics.
Companies in the Microbiomics market include Illumina, Thermo Fisher Scientific, Qiagen, BGI, and Pacific Biosciences. Show Less Read more